CHARLOTTESVILLE, Va., Aug. 2, 2016 /PRNewswire/ -- LumaCyte will be featured at NIWeek 2016 in Austin, Texas, USA from August 1st to 4th. Our Vice President of Software and Electronics, Dr. Christopher R. Field, will be presenting the Vision Summit keynote presentation on Tuesday, August 2nd. National Instruments (NI) is global company that holds its annual conference at the beginning of August to highlight innovative technologies that use their products. NI asked LumaCyte to present a keynote based on our advanced single cell analysis instrument, RadianceTM. Dr. Field will be presenting on the transformational Laser Force Cytology (LFC) technology developed by LumaCyte using NI tools. His presentation will feature the story of LumaCyte's successful transition from a prototype instrument into the cutting-edge product, RadianceTM, that it is today.
LumaCyte is an advanced research and instrument development company headquartered in Charlottesville, VA. LumaCyte produces next generation cell analysis and sorting instrumentation that does not require the use of antibody or genetic labelling for analysis of mammalian cells. This revolutionary technology utilizes optical and fluidic forces within a microfluidic device to identify and measure intrinsic properties of single cells. Applications of LumaCyte's label-free platform technology include viral infectivity, cancer biology, infectious disease, and pre-clinical drug discovery.
Since launching its flagship label-free single cell analysis instrument, Radiance, in April 2016, LumaCyte has been working with customers in the vaccine manufacturing space for rapid automated viral infectivity measurements. "The demand and interest from our customers has been huge and we are thrilled to be working with them to increase production efficiency and improve their manufacturing processes", says CEO Sean J. Hart